Profile data is unavailable for this security.
About the company
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
- Revenue in USD (TTM)12.80m
- Net income in USD-11.92m
- Incorporated2012
- Employees50.00
- LocationEkso Bionics Holdings Inc101 GLACIER POINT, SUITE ASAN RAFAEL 94901United StatesUSA
- Phone+1 (510) 984-1761
- Fax+1 (702) 866-2689
- Websitehttps://eksobionics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harvard Bioscience Inc | 87.37m | -53.84m | 26.43m | 330.00 | -- | 1.87 | -- | 0.3025 | -1.22 | -1.22 | 1.98 | 0.3156 | 0.8352 | 1.58 | 7.01 | 264,760.60 | -51.46 | -4.48 | -81.52 | -5.47 | 56.94 | 57.18 | -61.62 | -6.18 | 0.4081 | -0.5686 | 0.7071 | -- | -16.14 | -4.12 | -263.25 | -- | 21.83 | -- |
| PetVivo Holdings Inc | 1.11m | -10.21m | 27.31m | 24.00 | -- | 7.96 | -- | 24.57 | -0.3857 | -0.3857 | 0.0411 | 0.0981 | 0.2969 | 0.7874 | 4.25 | 46,318.33 | -265.20 | -195.28 | -557.27 | -346.33 | 66.05 | 74.58 | -893.26 | -1,163.49 | 0.787 | -4.52 | 0.00 | -- | 16.91 | 216.08 | 23.33 | -- | 49.21 | -- |
| Myomo Inc | 41.64m | -12.02m | 28.85m | 184.00 | -- | 1.97 | -- | 0.6927 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Guided Therapeutics Inc | 178.00k | -2.80m | 29.26m | 4.00 | -- | -- | -- | 164.38 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| Femasys Inc | 2.06m | -19.80m | 31.46m | 69.00 | -- | 5.59 | -- | 15.26 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| Vaso Corp | 89.11m | 2.59m | 31.60m | 298.00 | 12.23 | 1.12 | 9.54 | 0.3546 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 32.32m | 10.00 | -- | 4.00 | -- | 34.83 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| EUDA Health Holdings Ltd | 5.16m | -2.06m | 32.98m | 117.00 | 56.47 | -- | -- | 6.39 | 0.0155 | 0.0876 | 0.1483 | -0.0998 | 2.49 | -- | 17.10 | 44,104.96 | -100.77 | -- | -- | -- | 22.39 | -- | -40.53 | -- | 0.2084 | -46.54 | -- | -- | 8.22 | -- | -108.62 | -- | -- | -- |
| Precision Optics Corporation Inc | 24.42m | -6.92m | 33.66m | 90.00 | -- | 3.61 | -- | 1.38 | -0.9286 | -0.9286 | 3.25 | 1.21 | 1.21 | 5.44 | 5.83 | 271,288.60 | -34.24 | -13.63 | -57.54 | -19.51 | 9.70 | 29.56 | -28.33 | -11.58 | 0.6188 | -36.73 | 0.1454 | -- | -0.0685 | 13.98 | -95.85 | -- | 7.81 | -- |
| Neuroone Medical Technologies Corp | 8.72m | -6.83m | 33.70m | 18.00 | -- | 5.25 | -- | 3.87 | -0.1648 | -0.1648 | 0.1936 | 0.1270 | 1.16 | 2.19 | 3.47 | 484,231.70 | -90.61 | -113.64 | -111.55 | -152.08 | 54.87 | 60.94 | -78.34 | -223.44 | 5.09 | -- | 0.1119 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| Ekso Bionics Holdings Inc | 12.80m | -11.92m | 36.45m | 50.00 | -- | 4.03 | -- | 2.85 | -5.09 | -5.09 | 5.28 | 2.54 | 0.5474 | 1.27 | 1.76 | 255,980.00 | -50.02 | -37.99 | -76.46 | -49.47 | 53.48 | 52.48 | -91.37 | -86.20 | 1.07 | -- | 0.31 | -- | -28.60 | 7.58 | -5.22 | -- | -- | -- |
| TELA Bio Inc | 77.06m | -39.00m | 37.68m | 209.00 | -- | 22.30 | -- | 0.4889 | -0.8863 | -0.8863 | 1.75 | 0.0386 | 1.34 | 2.01 | 6.85 | 368,684.20 | -68.06 | -51.29 | -96.57 | -60.70 | 67.23 | 66.26 | -50.61 | -88.02 | 2.62 | -7.25 | 0.9638 | -- | 18.56 | 35.02 | 18.91 | -- | -18.18 | -- |
| Vivos Inc | 48.63k | -3.01m | 38.36m | 10.00 | -- | 17.60 | -- | 788.91 | -0.0068 | -0.0068 | 0.0001 | 0.0048 | 0.0275 | -- | 10.03 | -- | -170.12 | -166.49 | -178.25 | -242.01 | -127.33 | 2.81 | -6,191.01 | -11,105.98 | 19.81 | -- | 0.00 | -- | 43.59 | 24.13 | -0.5424 | -- | -- | -- |
| Precipio Inc | 22.80m | -1.25m | 43.24m | 54.00 | -- | 3.13 | 178.68 | 1.90 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Spectral AI Inc | 23.17m | -16.37m | 43.27m | 78.00 | -- | -- | -- | 1.87 | -0.7206 | -0.7206 | 0.9706 | -0.301 | 1.72 | 28.41 | 12.12 | 297,025.70 | -121.66 | -- | -- | -- | 45.01 | -- | -70.64 | -- | 0.8252 | -11.99 | -- | -- | 63.83 | -- | 26.56 | -- | -- | -- |
| Icecure Medical Ltd | 2.98m | -15.29m | 43.87m | 64.00 | -- | 4.71 | -- | 14.75 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
Data as of Mar 03 2026. Currency figures normalised to Ekso Bionics Holdings Inc's reporting currency: US Dollar USD
7.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| DBA Trading LLCas of 22 Jan 2026 | 156.76k | 4.62% |
| Geode Capital Management LLCas of 31 Dec 2025 | 25.21k | 0.74% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 18.65k | 0.55% |
| Cresset Asset Management LLCas of 31 Dec 2025 | 17.96k | 0.53% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 16.80k | 0.50% |
| Scientech Research LLCas of 31 Dec 2025 | 10.39k | 0.31% |
| IMPact SGR SpAas of 30 Sep 2025 | 3.67k | 0.11% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.65k | 0.11% |
| Banque Lombard Odier & Cie SA (Investment Management)as of 31 Dec 2025 | 1.67k | 0.05% |
| Golden State Wealth Management LLCas of 31 Dec 2025 | 1.30k | 0.04% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
